RVMDW vs RUSHB: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

RUSHB has stronger fundamentals based on our AI analysis.

RVMDW
Revolution Medicines, Inc.
STRONG SELL
88%
Confidence
VS
RUSHB
RUSH ENTERPRISES INC \TX\
HOLD
75%
Confidence

RVMDW vs RUSHB Fundamental Comparison

Metric RVMDW RUSHB
Revenue $0.0 $7.4B
Net Income $-1.1B $263.8M
Net Margin N/A 3.5%
ROE -69.3% 12.0%
ROA -48.0% 6.0%
Current Ratio 7.14x 1.40x
Debt/Equity 0.00x 0.12x
EPS $-5.95 $3.27

Green = Better metric | Red = Weaker metric

View Full RVMDW Analysis →
View Full RUSHB Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

RVMDW vs AAPL RUSHB vs MSFT RVMDW vs GOOGL RUSHB vs AMZN

RVMDW vs RUSHB: Frequently Asked Questions

Is RVMDW or RUSHB a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), RUSHB has stronger fundamentals. RVMDW is rated STRONG SELL (88% confidence) while RUSHB is rated HOLD (75% confidence). This is not investment advice.

How does RVMDW compare to RUSHB fundamentally?

Revolution Medicines, Inc. has ROE of -69.3% vs RUSH ENTERPRISES INC \TX\'s 12.0%. Net margins are N/A vs 3.5% respectively.

Which stock pays higher dividends, RVMDW or RUSHB?

RVMDW has a dividend yield of N/A or no dividend while RUSHB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in RVMDW or RUSHB for long term?

For long-term investing, consider that RVMDW has STRONG SELL rating with 88% confidence, while RUSHB has HOLD rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about RVMDW vs RUSHB?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RVMDW vs RUSHB, the AI consensus favors RUSHB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.